What are the common antibiotics used for various infections?

Five Most Commonly Used Antibiotics for Various Infections

The five most commonly used antibiotics for treating various infections are amoxicillin-clavulanate, trimethoprim-sulfamethoxazole (TMP-SMX), doxycycline, clindamycin, and vancomycin, based on their broad spectrum of activity and effectiveness against common pathogens. 1, 2

1. Amoxicillin-Clavulanate

Amoxicillin-clavulanate is a first-line antibiotic for many common infections due to its broad spectrum of activity.

• Formulations and Dosing:

  • Adult dosing: 875/125 mg PO every 12 hours or 500/125 mg PO every 8 hours 2, 3
  • Pediatric dosing: 45 mg/kg/day divided every 12 hours or 40 mg/kg/day divided every 8 hours 2
  • Should be taken with food to reduce gastrointestinal upset 3

• Key Indications:

  • Skin and soft tissue infections
  • Respiratory tract infections
  • Otitis media
  • Animal and human bites 2

• Clinical Pearls:

  • Twice daily formulations improve compliance and reduce gastrointestinal side effects due to lower daily clavulanate dose 4
  • Effective against beta-lactamase producing organisms including H. influenzae and many strains of E. coli 5, 6

2. Trimethoprim-Sulfamethoxazole (TMP-SMX)

TMP-SMX is particularly valuable for MRSA infections and urinary tract infections.

• Dosing:

  • Adult dosing: 160-320/800-1600 mg PO every 12 hours 1
  • Used for outpatient treatment of skin and soft tissue infections, particularly those caused by MRSA 1

• Key Indications:

  • MRSA skin infections
  • Urinary tract infections
  • Diabetic foot infections 1

• Clinical Pearls:

  • Effective for empiric treatment of community-acquired MRSA
  • May be used for 7-day course in pyelonephritis when the pathogen is susceptible 1

3. Doxycycline

Doxycycline is a tetracycline antibiotic with excellent tissue penetration and broad spectrum activity.

• Dosing:

  • Adult dosing: 100 mg PO every 12 hours 1
  • For patients ≤45 kg: 2 mg/kg/dose PO every 12 hours 1

• Key Indications:

  • Skin and soft tissue infections, including MRSA
  • Respiratory tract infections
  • Sexually transmitted infections 2

• Clinical Pearls:

  • Contraindicated in children under 8 years due to dental staining 2
  • Should not be used in pregnancy 2
  • Can be used as monotherapy for MRSA skin infections or in combination with a beta-lactam for broader coverage 1

4. Clindamycin

Clindamycin is particularly useful for anaerobic and gram-positive infections.

• Dosing:

  • Adult dosing: 300-450 mg PO every 8 hours or 600-900 mg IV every 8 hours 1
  • Pediatric dosing: 10-20 mg/kg/day PO in 3 divided doses or 25-40 mg/kg/day IV in 3 divided doses 2

• Key Indications:

  • Skin and soft tissue infections
  • Anaerobic infections
  • Necrotizing fasciitis (in combination with penicillin) 1
  • Streptococcal toxic shock syndrome 1

• Clinical Pearls:

  • Suppresses toxin production in streptococcal infections 1
  • Risk of Clostridioides difficile infection is a concern 2
  • Increasing resistance among staphylococci limits empiric use in some areas 1

5. Vancomycin

Vancomycin is a glycopeptide antibiotic crucial for treating serious gram-positive infections.

• Dosing:

  • Adult dosing: 30-60 mg/kg/day IV in 2-4 divided doses 1
  • Loading dose of 25-30 mg/kg recommended for seriously ill patients 1

• Key Indications:

  • MRSA infections
  • Complicated skin and soft tissue infections
  • Endocarditis
  • Bacteremia 1

• Clinical Pearls:

  • Requires therapeutic drug monitoring to ensure efficacy and avoid toxicity 2
  • For skin infections, 7-14 days of therapy is typically recommended 1
  • May be less effective than linezolid for MRSA skin infections based on some studies 1

Special Considerations

• Duration of Therapy:

  • Skin and soft tissue infections: 5-10 days (uncomplicated) to 7-14 days (complicated) 1
  • Shorter courses (5-6 days) may be sufficient for non-purulent cellulitis in patients able to self-monitor 1

• Antibiotic Selection Based on Infection Type:

  • For purulent skin infections (likely S. aureus): Dicloxacillin, cefazolin, clindamycin, doxycycline, or TMP-SMX 1
  • For non-purulent infections (likely streptococcal): Penicillin, clindamycin, cefazolin, or cefalexin 1
  • For mixed infections: Combination therapy or broad-spectrum agents like piperacillin-tazobactam 1

• Resistance Considerations:

  • Local resistance patterns should guide empiric therapy choices 2
  • Narrow spectrum when culture results are available to reduce resistance development 2, 3

By selecting the appropriate antibiotic based on the suspected pathogen, infection site, and patient factors, clinicians can optimize treatment outcomes while minimizing adverse effects and resistance development.